Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Of Granting Of Patent

With reference to captioned subject and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Controller of Patent, Indian Patent Office, Government of India has granted on 29th May 2023 a Patent for invention entitled PROCESS FOR THE PREPARATION OF CARCINOGENIC AZIDO IMPURITIES FREE LOSARTAN AND SALTS thereof. Losartan is a drug used for treatment of hypertension. This is for your information and records.
29-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issue of letter of confirmation dated 25th May 2023 to the shareholders in lieu of the lost share certificates
26-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and year ended 31st March 2023
17-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Submission Of Voting Results & Scrutinizer'S Report Of Postal Ballot Of IOL Chemicals And Pharmaceuticals Limited

Submission of Voting Results & Scrutinizer's Report of Postal Ballot of IOL Chemicals and Pharmaceuticals Limited
12-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Recording of Analysts/Investors Call pertaining to the Financial Results 4Q & FY23
10-05-2023

IOL Chemicals and Pharmaceuticals Results Earnings Call for Q4FY23

Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
09-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We wish to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is organizing an analyst /investor conference call on Tuesday, 09th May, 2023 at 3:00 PM (IST) to discuss the financial performance of the Company for the Q4 and FY23. The invite of the same is attached herewith.
08-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We wish to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is organizing an analyst /investor conference call on Tuesday, 09th May, 2023 at 3:00 PM (IST) to discuss the financial performance of the Company for the Q4 and FY23. The invite of the same is attached herewith.
08-05-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release: IOL Chemicals and Pharmaceuticals Receives CEP for Paracetamol to Export in European Market
08-05-2023
Next Page
Close

Let's Open Free Demat Account